Dechloro Rivaroxaban

CAS No. 1415566-28-7

Dechloro Rivaroxaban( —— )

Catalog No. M37156 CAS No. 1415566-28-7

Dechloro Rivaroxaban is an orally active and highly selective Factor Xa inhibitor.Dechloro Rivaroxaban has a significant inhibitory effect on free FXa in humans.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 46 Get Quote
10MG 77 Get Quote
25MG 144 Get Quote
50MG 227 Get Quote
100MG 356 Get Quote
500MG 963 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Dechloro Rivaroxaban
  • Note
    Research use only, not for human use.
  • Brief Description
    Dechloro Rivaroxaban is an orally active and highly selective Factor Xa inhibitor.Dechloro Rivaroxaban has a significant inhibitory effect on free FXa in humans.
  • Description
    Dechloro Rivaroxaban is a highly selective, orally active inhibitor of Factor Xa. Dechloro Rivaroxaban inhibits human free FXa with a Ki of 0.4 nM. Dechloro Rivaroxaban inhibits prothrombinase activity and fibrin-associated FXa activity with IC50s of 2.1 nM and 92 nM, respectively.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Factor Xa
  • Recptor
    Factor Xa
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1415566-28-7
  • Formula Weight
    401.44
  • Molecular Formula
    C19H19N3O5S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (124.55 mM; Ultrasonic )
  • SMILES
    O=C(NC[C@H]1CN(C(=O)O1)c1ccc(cc1)N1CCOCC1=O)c1cccs1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Lang D, et al. In vitro metabolism of rivaroxaban, an oral, direct factor Xa inhibitor, in liver microsomes and hepatocytes of rats, dogs, and humans. Drug Metab Dispos. 2009 May;37(5):1046-55.?
molnova catalog
related products
  • Eribaxaban

    A potent, selective and orally efficacious factor Xa (FXa) inhibitor with IC50 of 0.32 nM.

  • Edoxaban (b)

    A potent and orally active Factor Xa inhibitor with Ki of 0.561 nM.

  • EMD-503982

    EMD-503982 is a potential Factor Xa and Factor VIIa inhibitor with potential anticancer and antitumor activity for the study of thromboembolic and neurological disorders.